Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

Press releases published on November 6, 2026

Nov. 6, 2026

Azalea Therapeutics Presents New Preclinical Data at SITC 2026 Highlighting Durable Anti-Tumor Activity and Modular Capabilities of its In Vivo CAR T Cell Platform

Indeterminate GlobeNewswire

Nov. 6, 2026

BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Immunity in Advanced Ovarian Cancer

Indeterminate GlobeNewswire

Nov. 6, 2026

Minerva Neurosciences Provides Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 6, 2026

APA Applauds Medicare Payment Increases for Collaborative Care

Indeterminate GlobeNewswire

Nov. 6, 2026

ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Nov. 6, 2026

Quoin Pharmaceuticals’ Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome

Indeterminate GlobeNewswire

Nov. 6, 2026

CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing Approval Application

Indeterminate GlobeNewswire

Nov. 6, 2026

バイオカーディア、カーディAMP細胞治療システムに関して日本のPMDAとの臨床相談手続を完了し、販売承認申請の提出に向けて進捗

Indeterminate GlobeNewswire

Nov. 6, 2026

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook

Indeterminate GlobeNewswire

Nov. 6, 2026

CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 6, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 6, 2026

Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week's Inaugural 2026 Awards

Indeterminate GlobeNewswire

Nov. 6, 2026

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 6, 2026

Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire

Nov. 6, 2026

MIMEDX to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 6, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union

Indeterminate GlobeNewswire